Association between microscopic hematuria and albuminuria in patients with chronic kidney disease caused by diabetes and hypertension: the Fukuoka Kidney disease Registry Study

被引:1
作者
Nakagawa, Kaneyasu [1 ,2 ,3 ]
Tanaka, Shigeru [1 ]
Tsuruya, Kazuhiko [4 ]
Kitazono, Takanari [1 ]
Nakano, Toshiaki [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, 3-1-1 Maidashi, Higashi, Fukuoka 8128582, Japan
[2] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan
[3] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan
[4] Nara Med Univ, Dept Nephrol, Kashihara, Nara, Japan
关键词
Albuminuria; Microscopic hematuria; Chronic kidney disease; Diabetic nephropathy and hypertensive nephrosclerosis; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; IGA NEPHROPATHY; RISK-FACTOR; PROTEINURIA; PROGRESSION; INJURY; DEFINITION; MORTALITY; EXCRETION;
D O I
10.1007/s10157-022-02298-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The association between microscopic hematuria (MH) and albuminuria in patients with chronic kidney disease (CKD) caused by diabetes and hypertension remains unclear. Methods The Fukuoka Kidney disease Registry Study is a Japanese multicenter prospective cohort study of 4476 patients with non-dialysis-dependent CKD. In this cohort, we conducted a cross-sectional study in 994 patients with diabetic nephropathy and hypertensive nephrosclerosis. Patients were divided into three groups according to erythrocyte count in urine sediment [T1: < 5/high power field (HPF); T2: 5-9/HPF; T3: >= 10/HPF]. Macroalbuminuria was defined as urinary albumin-creatinine ratio > 300 mg/g. Associations between the degree of MH (T1-T3) and the prevalence of macroalbuminuria were analyzed using logistic regression. Results The prevalence of macroalbuminuria was 50.8%, 50.4%, and 67.4% in T1 (n = 725), T2 (n = 226), and T3 (n = 43), respectively. The multivariable-adjusted odds ratios for the presence of macroalbuminuria were 0.95 [95% confidence interval (CI) 0.65-1.39; P = 0.86] and 2.50 (95% CI 1.15-5.47; P = 0.022) for patients in T2 and T3, respectively, compared with patients in T1. Conclusions MH with erythrocytes >= 10/HPF was significantly associated with increased prevalence of macroalbuminuria in patients with non-dialysis-dependent CKD caused by diabetes and hypertension.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [31] Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Lambelet, Marc
    Lawatscheck, Robert
    Bakris, George L.
    Ruilope, Luis M.
    Agarwal, Rajiv
    [J]. JACC-HEART FAILURE, 2022, 10 (11) : 860 - 870
  • [32] Association of serum adiponectin level with albuminuria in chronic kidney disease patients
    Ha Yeon Kim
    Eun Hui Bae
    Seong Kwon Ma
    Dong Wan Chae
    Kyu Hun Choi
    Yong-Soo Kim
    Young-Hwan Hwang
    Curie Ahn
    Soo Wan Kim
    [J]. Clinical and Experimental Nephrology, 2016, 20 : 443 - 449
  • [33] Associations Between Surrogates of Skeletal Muscle Mass and History of Bone Fracture in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry (FKR) Study
    Yamada, Shunsuke
    Tanaka, Shigeru
    Arase, Hokuto
    Hiyamuta, Hiroto
    Yoshizumi, Eriko
    Tokumoto, Masanori
    Nakano, Toshiaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2021, 109 (04) : 393 - 404
  • [34] Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease
    Haruyama, Naoki
    Nakayama, Masaru
    Fukui, Akiko
    Yoshitomi, Ryota
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (08) : 687 - 700
  • [35] Associations Between Surrogates of Skeletal Muscle Mass and History of Bone Fracture in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry (FKR) Study
    Shunsuke Yamada
    Shigeru Tanaka
    Hokuto Arase
    Hiroto Hiyamuta
    Eriko Yoshizumi
    Masanori Tokumoto
    Toshiaki Nakano
    Kazuhiko Tsuruya
    Takanari Kitazono
    [J]. Calcified Tissue International, 2021, 109 : 393 - 404
  • [36] Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study
    Fraser, Simon D. S.
    Parkes, Julie
    Culliford, David
    Santer, Miriam
    Roderick, Paul J.
    [J]. BMC FAMILY PRACTICE, 2015, 16
  • [37] New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease
    Sokolova, A. A.
    Skripka, A., I
    Ivanov, I. I.
    Kogay, V. V.
    Listratov, A., I
    Gindis, A. A.
    Napalkov, D. A.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (03) : 423 - 428
  • [38] Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease
    Fernandez-Fernandez, Beatriz
    Mahillo, Ignacio
    Sanchez-Rodriguez, Jinny
    Carriazo, Sol
    Sanz, Ana B.
    Sanchez-Nino, Maria Dolores
    Ortiz, Alberto
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [39] Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study
    Chu, Lisa
    Fuller, Mark
    Jervis, Kathyrn
    Ciaccia, Antonio
    Abitbol, Alexander
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (09) : 1558 - +
  • [40] Cardiovascular Disease in Diabetes and Chronic Kidney Disease
    Swamy, Sowmya
    Noor, Sahibzadi Mahrukh
    Mathew, Roy O.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)